|
|
Accueil > Produits & Services > The Pharmacokinetic Cube > Auteurs > PD Dr Joachim Mayer
QUELQUES PUBLICATIONS
| 1. |
Planchamp C, Ivancevic MK, Pastor CM, Vallee JP, Pochon
S, Terrier F, Mayer JM, Reist M. |
|
Hollow fiber bioreactor: new development for the study
of contrast agent transport into hepatocytes by magnetic resonance
imaging.
Biotechnol Bioeng. 2004 Mar 20;85(6):656-65. |
|
|
| 2. |
Berger J, Reist M, Mayer JM, Felt O, Gurny R.
Structure and interactions in chitosan hydrogels formed by complexation
or aggregation for biomedical applications.
Eur
J Pharm Biopharm. 2004 Jan;57(1):35-52. Review. |
|
|
| 3. |
Berger J, Reist M, Mayer JM, Felt O, Peppas NA, Gurny
R.
Structure and interactions in covalently and ionically crosslinked
chitosan hydrogels for biomedical applications.
Eur
J Pharm Biopharm. 2004 Jan;57(1):19-34. Review. |
|
|
| 4. |
Planchamp C, Vu TL, Mayer JM, Reist M, Testa B.
Hepatocyte hollow-fibre bioreactors: design, set-up, validation and
applications.
J. Pharm Pharmacol. 2003 Sep;55(9):1181-98. Review. |
|
|
| 5. |
Furrer P, Mayer JM, Plazonnet B, Gurny R.
Ocular tolerance of absorption enhancers in ophthalmic preparations.
AAPS PharmSci. 2002;4(1):E2. |
|
|
| 6 |
Chapuis N, Bruhlmann C, Reist M, Carrupt PA, Mayer JM,
Testa B.
The esterase-like activity of serum albumin may be due to cholinesterase
contamination. Pharm Res. 2001 Oct;18(10):1435-9. |
|
|
| 7. |
Furrer P, Berger J, Mayer JM, Gurny R.
A comparative study of the ocular tolerance of 3 timolol-based preparations:
the influence of preservatives on ocular tolerance J Fr Ophtalmol.
2001 Jan;24(1):13-9. French. |
|
|
| 8. |
Reist M, Roy-de Vos M, Montseny JP, Mayer JM, Carrupt
PA, Berger Y, Testa B. Very slow chiral inversion of clopidogrel in
rats: a pharmacokinetic and mechanistic investigation. Drug Metab
Dispos. 2000 Dec;28(12):1405-10. |
|
|
| 9. |
Furrer P, Plazonnet B, Mayer JM, Gurny R.
Application of in vivo confocal microscopy to the objective evaluation
of ocular irritation induced by surfactants. Int J Pharm. 2000 Oct
10;207(1-2):89-98. |
|
|
| 10. |
De Carlo S, Adrian M, Kalin P, Mayer JM, Dubochet J.
Unexpected property of trehalose as observed by cryo-electron microscopy.
J Microsc. 1999 Oct;196(1):40-45. |
|
|
| 11. |
Felt O, Furrer P, Mayer JM, Plazonnet B, Buri P, Gurny
R.
Topical use of chitosan in ophthalmology: tolerance assessment and
evaluation of precorneal retention. Int J Pharm. 1999 Apr 15;180(2):185-93. |
|
|
| 12. |
Furrer P, Mayer JM, Plazonnet B, Gurny R.
Ocular tolerance of preservatives on the murine cornea. Eur J Pharm
Biopharm. 1999 Mar;47(2):105-12. |
|
|
| 13. |
Testa B, Mayer JM.
Design of intramolecularly activated prodrugs. Drug Metab Rev. 1998
Nov;30(4):787-807. Review. |
|
|
| 14. |
F urrer P, Mayer JM, Gurny R.
Confocal microscopy as a tool for the investigation of the anterior
part of the eye. J Ocul Pharmacol Ther. 1997 Dec;13(6):559-78. Review. |
|
|
| 15. |
Salvi A, Carrupt PA, Mayer JM, Testa B.
Esterase-like activity of human serum albumin toward prodrug esters
of nicotinic acid. Drug Metab Dispos. 1997 Apr;25(4):395-8. |
|
|
| 16. |
Mayer JM.
Ibuprofen enantiomers and lipid metabolism. J Clin Pharmacol. 1996
Dec;36(12 Suppl):27S-32S. |
|
|
| 17. |
Salvi A, Mayer JM, Carrupt PA, Testa B.
A continuous fluorimetric method to monitor the enzymatic hydrolysis
of medicinal esters. J Pharm Biomed Anal. 1996 Nov;15(2):149-55. |
|
|
| 18. |
Roy-de Vos M, Mayer JM, Etter JC, Testa B.
Clofibric acid increases the undirectional chiral inversion of ibuprofen
in rat liver preparations. Xenobiotica. 1996 Jun;26(6):571-82. |
|
|
| 19. |
Gabard B, Nirnberger G, Schiel H, Mascher H, Kikuta
C, Mayer JM.
Comparison of the bioavailability of dexibuprofen administered alone
or as part of racemic ibuprofen. Eur J Clin Pharmacol. 1995;48(6):505-11. |
|
|
| 20. |
Mayer JM, Testa B, Roy-de Vos M, Audergon C, Etter JC.
Interactions between the in vitro metabolism of xenobiotics and fatty
acids. The case of ibuprofen and other chiral profens. Arch Toxicol
Suppl. 1995;17:499-513. Review. |
|
|
| 21. |
Van Gelderen H, Mayer JM, Testa B.
Thermodynamic studies of enzyme catalysis. What can we learn about
specificity and mechanism? Biochem Pharmacol. 1994 Mar 2;47(5):753-6. |
|
|
| 22. |
Van Gelderen H, Mayer JM, Cellamare S, Testa B.
The temperature dependence of steady-state kinetics: what can be learned
about pig liver esterase stereospecificity? Chirality. 1994;6(1):11-6. |
|
|
| 23. |
Mayer JM, Roy-De Vos M, Audergon C, Testa B, Etter JC.
Interactions of anti-inflammatory 2-arylpropionates (profens) with
the metabolism of fatty acids: in vitro studies. Int J Tissue React.
1994;16(2):59-72. Review. |
|
|
| 24. |
Magada M, Mayer JM, Etter JC.
Development of an ocular irritation test in the mouse: image analysis
of corneal lesions. Food Chem Toxicol. 1993 Mar;31(3):219-24. |
|
|
| 25. |
Muller S, Mayer JM, Etter JC, Testa B.
Influence of palmitate and benzoate on the unidirectional chiral inversion
of ibuprofen in isolated rat hepatocytes. Biochem Pharmacol. 1992
Oct 6;44(7):1468-70. |
|
|
| Exhaustive List is available at pubmed.com |
|
